𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Nuclear structure as a source of cancer specific biomarkers

✍ Scribed by Eddy S. Leman; Robert H. Getzenberg


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
74 KB
Volume
104
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

There are few biomarkers that have been developed which have proven clinical utility for the detection and prognosis of cancer. Cancer is diagnosed today, in large part, by examining cells under the microscope and determining the shape and texture of the nucleus. The molecular underpinnings of this hallmark of cancer are the components of the nuclear matrix. Utilizing proteomics focused on this subset of proteins, biomarkers have been identified that are specific for cancer types including prostate, colon and bladder cancer. These cancer biomarkers now serve as the basis of assays which can specifically identify individuals with cancer by sampling their blood and/or urine. In addition, these may serve as potential therapeutic targeting or imaging approaches. J. Cell. Biochem. 104: 1988–1993, 2008. Β© 2007 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Nuclear structural proteins as biomarker
✍ Badrinath R. Konety; Robert H. Getzenberg πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 67 KB πŸ‘ 1 views

The regulation of cell processes is integrally connected to cellular and extracellular structure. Studies over the past three decades have demonstrated the complex interactions of cell structure and function. The relationship of cellular structure and function has perhaps been most studied in the tr

Udp-glucose dehydrogenase as a novel fie
✍ Dali Huang; George P. Casale; Jun Tian; Subodh M. Lele; Vladimir M. Pisarev; Mel πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 432 KB

## Abstract Uridine diphosphate **(**UDP)‐glucose dehydrogenase (UGDH) catalyzes the oxidation of UDP‐glucose to yield UDP‐glucuronic acid, a precursor for synthesis of glycosaminoglycans and proteoglycans that promote aggressive prostate cancer (PC) progression. The purpose of our study was to det

Identification of specific nuclear struc
✍ Manuel Debald; Sebastian Franken; Lukas Carl Heukamp; Andrea Linke; Matthias Wol πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 419 KB πŸ‘ 1 views

## Abstract Breast cancer is the most commonly diagnosed type of cancer and a major cause of death in women. Reliable biomarkers are urgently needed to improve early detection or to provide evidence of the prognosis for each individual patient through expression levels in tumor tissue or body fluid

Nuclear morphometry as a biomarker for b
✍ Martial Guillaud; Jean C. le Riche; Chris Dawe; Jagoda Korbelik; Andy Coldman; I πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 268 KB

## Abstract ## Background Bronchial carcinomas are preceded by epithelial morphologic changes. The variation in interpretation of these grades of intraepithelial neoplasia makes it difficult to determine its natural history and utility of histopathology as a surrogate endpoint biomarker. The objec

Oncogenic microRNAs (OncomiRs) as a new
✍ Vladimir A. Krutovskikh; Zdenko Herceg πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 224 KB πŸ‘ 2 views

## Abstract Small non‐coding RNAs (microRNAs or miRs) represent one of the most fertile areas of cancer research and recent advances in the field have prompted us to reconsider the traditional concept of cancer. Some miRs exert negative control over the expression of numerous oncoproteins in normal